These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20627867)

  • 21. Loops govern SH2 domain specificity by controlling access to binding pockets.
    Kaneko T; Huang H; Zhao B; Li L; Liu H; Voss CK; Wu C; Schiller MR; Li SS
    Sci Signal; 2010 May; 3(120):ra34. PubMed ID: 20442417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of phosphorylated FcepsilonRIgamma immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics.
    Chen T; Repetto B; Chizzonite R; Pullar C; Burghardt C; Dharm E; Zhao Z; Carroll R; Nunes P; Basu M; Danho W; Visnick M; Kochan J; Waugh D; Gilfillan AM
    J Biol Chem; 1996 Oct; 271(41):25308-15. PubMed ID: 8810294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of binding sites of peptide recognition domains: an application on Grb2 and SAP SH2 domains.
    McLaughlin WA; Hou T; Wang W
    J Mol Biol; 2006 Apr; 357(4):1322-34. PubMed ID: 16476443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
    Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
    Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
    Gay B; Furet P; García-Echeverría C; Rahuel J; Chène P; Fretz H; Schoepfer J; Caravatti G
    Biochemistry; 1997 May; 36(19):5712-8. PubMed ID: 9153411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SH2 domain binding to phosphopeptide ligands: potential for drug targeting.
    Kasembeli MM; Xu X; Tweardy DJ
    Front Biosci (Landmark Ed); 2009 Jan; 14(3):1010-22. PubMed ID: 19273114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of phosphotyrosine signaling networks using a scoring matrix-assisted ligand identification approach.
    Li L; Wu C; Huang H; Zhang K; Gan J; Li SS
    Nucleic Acids Res; 2008 Jun; 36(10):3263-73. PubMed ID: 18424801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains.
    Sheinerman FB; Al-Lazikani B; Honig B
    J Mol Biol; 2003 Dec; 334(4):823-41. PubMed ID: 14636606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity.
    Stein EG; Ghirlando R; Hubbard SR
    J Biol Chem; 2003 Apr; 278(15):13257-64. PubMed ID: 12551896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational determinants of phosphotyrosine peptides complexed with the Src SH2 domain.
    Nachman J; Gish G; Virag C; Pawson T; Pomès R; Pai E
    PLoS One; 2010 Jun; 5(6):e11215. PubMed ID: 20574521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the specificity space of the human SRC homology 2 domain.
    Huang H; Li L; Wu C; Schibli D; Colwill K; Ma S; Li C; Roy P; Ho K; Songyang Z; Pawson T; Gao Y; Li SS
    Mol Cell Proteomics; 2008 Apr; 7(4):768-84. PubMed ID: 17956856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct determination of the sequence recognition requirements of the SH2 domains of SH-PTP2.
    Huyer G; Li ZM; Adam M; Huckle WR; Ramachandran C
    Biochemistry; 1995 Jan; 34(3):1040-9. PubMed ID: 7530043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single point mutation switches the specificity of group III Src homology (SH) 2 domains to that of group I SH2 domains.
    Songyang Z; Gish G; Mbamalu G; Pawson T; Cantley LC
    J Biol Chem; 1995 Nov; 270(44):26029-32. PubMed ID: 7592796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.
    Muller AJ; Pendergast AM; Havlik MH; Puil L; Pawson T; Witte ON
    Mol Cell Biol; 1992 Nov; 12(11):5087-93. PubMed ID: 1383690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comprehensive Immunoreceptor Phosphotyrosine-based Signaling Network Revealed by Reciprocal Protein-Peptide Array Screening.
    Liu H; Li L; Voss C; Wang F; Liu J; Li SS
    Mol Cell Proteomics; 2015 Jul; 14(7):1846-58. PubMed ID: 25907764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand.
    Malek SN; Desiderio S
    J Biol Chem; 1994 Dec; 269(52):33009-20. PubMed ID: 7528743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
    Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
    Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display.
    Li A; Voleti R; Lee M; Gagoski D; Shah NH
    Elife; 2023 Mar; 12():. PubMed ID: 36927728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.